Dr. Benjamin Waldmann

Dr. Benjamin Waldmann has extensive work experience in the medical industry. Dr. Benjamin is currently the CEO of Xenios AG, a Fresenius Medical Care company. Prior to this role, they held various positions at Fresenius Medical Care, including Senior Vice President of Heart, Lung, and Therapeutic Apheresis. Dr. Benjamin also served as Vice President of HD Devices and Vice President of Machines Germany. Before joining Fresenius, Dr. Waldmann worked at Siemens Healthineers as the Head of Medical Electronic R&D Customer Management and Team Manager for RF and Mixed-Signal Processing. Dr. Benjamin also worked at Siemens as a Program Manager and Development Engineer. Dr. Benjamin started their career as a Research Assistant at the Friedrich-Alexander-University of Erlangen-Nürnberg.

Dr. Benjamin Waldmann received their education in Elektrotechnik, Elektronik und Informationstechnik. Dr. Benjamin obtained a Diplom Ingenieur degree from FAU Erlangen-Nürnberg in 2006. Subsequently, they earned a Dr.-Ing. degree from the same institution in 2010.

Location

Nuremberg, Germany

Links

Previous companies


Org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Xenios AG - a Fresenius Medical Care company

At Xenios, a Fresenius Medical Care company, we offer ECMO treatments for patients suffering from cardiac and/or pulmonary failure. Based on a holistic understanding of human physiology, we develop intelligent technological solutions that can be vital for the survival of critically ill patients. We offer solutions that combine both cardiac and pulmonary support on one single technological platform. It supports the gas exchange in the lungs and the cardiovascular system to keep patients alive. The physician thus gains more vital treatment time during diagnosis and therapy. Xenios is part of Fresenius Medical Care, the world's leading provider of products and services for people with renal diseases. We are complementing Fresenius Medical Care’s product portfolio in the field of intensive care and are continuing to shape the future of extracorporeal multi-organ support. In our daily work, we share a passion for helping people. For patients. Worldwide. Every day.


Headquarters

Heilbronn, Germany

Employees

201-500

Links